it appears the question of efficacy for SB is nearly confirmed by fda this month. so the next market risk is pipeline of new platforms, which is robust. if you believe in those platforms - than the only question is which (USA) Pharma company is the natural acquirer. and more importantly for shareholders: is it a strategic or economic multiple paid. I believe the terminal value is 3-5 aud per share in the next 5 years.
- Forums
- ASX - By Stock
- BOT
- BOT - Anything but charting
BOT - Anything but charting, page-5737
-
-
- There are more pages in this discussion • 5,346 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.5¢ |
Change
0.005(1.35%) |
Mkt cap ! $671.1M |
Open | High | Low | Value | Volume |
37.0¢ | 39.0¢ | 37.0¢ | $771.7K | 2.030M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 198576 | 37.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 135392 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 198576 | 0.375 |
21 | 375935 | 0.370 |
14 | 478631 | 0.365 |
14 | 244420 | 0.360 |
17 | 321656 | 0.355 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 135392 | 18 |
0.385 | 235338 | 9 |
0.390 | 124963 | 6 |
0.395 | 173274 | 6 |
0.400 | 157800 | 4 |
Last trade - 13.29pm 09/10/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online